Impact of restrictive (Sleeve Gastrectomy) vs hybrid bariatric surgery (roux-en-y gastric bypass) on lipid profile

Obesity Surgery

Volumn 22, Issue 8, 2012, Pages 1268-1275

  Benaiges, D ^a,b   Flores Le Roux, J A ^a,b   Pedro Botet, J ^a,b   Ramon, J M ^a   Parri, A ^a   Villatoro, M ^a   Carrera, M J ^a   Pera, M ^a   Sagarra, E ^a   Grande, L ^a   Goday, A ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cholesterol; Laparoscopic Roux en Y gastric bypass; Laparoscopic sleeve gastrectomy; Lipid profile; Triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PERIOPERATIVE COMPLICATION; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; TREATMENT INDICATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; COHORT STUDIES; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GASTROPLASTY; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84864877955     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0662-8     Document Type: Article

References (39)

1. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008;17:1063-71.
2. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA. 2004;292:1724-37.
3. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909-17.
4. Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861-4.
5. Leyba JL, Aulestia SN, Llopis SN. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of severe obesity. A prospective study of 117 patients. Obes Surg. 2010;21:212-6.
6. Birkmeyer NJ, Dimick JB, Share D, et al. Michigan Bariatric Surgery Collaborative. Hospital complication rates with bariatric surgery in Michigan. JAMA. 2010;304:435-42.
7. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2009;24:1005-21.
8. Tucker ON, Szomstein S, Rosenthal RJ. Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese. J Gastrointest Surg. 2008;12:662-7.
9. Gill RS, Karmali S, Sharma AM. Treating type 2 diabetes mellitus with sleeve gastrectomy in obese patients. Obesity. 2011;19:701-2.
10. Peterli R, Wölnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: Comparison of laparoscopic Rouxen- Y gastric bypass and laparoscopic sleeve gastrectomy: A prospective randomized trial. Ann Surg. 2009;250:234-41.
11. Lakdawala MA, Bhasker A, Mulchandani D, et al. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: A retrospective 1year study. Obes Surg. 2010;20:1-6.
12. Vidal J, Ibarzabal A, Nicolau J, et al. Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17:1069-74.
13. Athyros VG, Tziomalos K, Karagiannis A, et al. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obes Rev. 2011;12:515-24.
14. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.
15. Dhabuwala A, Cannan RJ, Stubbs RS. Improvement in comorbidities following weight loss from gastric bypass surgery. Obes Surg. 2000;10:428-35.
16. Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006;203:24-9.
17. Habib P, Scrocco JD, Terek M, et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104:1251-5.
18. Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51:2405-12.
19. Pihlajamäki J, Grönlund S, Simonen M, et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010;59:866-72.
20. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: A prospective, double blind study. Ann Surg. 2008;247:401-7.
21. Hubbard VS, Hall WH. National Institutes of Health Consensus Development Conference Draft statement on gastrointestinal surgery for severe obesity. Obes Surg. 1991;1:257-65.
22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.
23. Chobanian AV, Bakris GL, Black HR, et al. Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-72.
24. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;218:499-502.
26. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-9.
27. Dixon JB, O'Brien PE. Lipid profile in the severely obese: Changes with weight loss after lap-band surgery. Obesity. 2002;10:903-10.
28. Hanusch-Enserer U, Zorn G, Wojta J, et al. Non-conventional markers of atherosclerosis before and after gastric banding surgery. Eur Heart J. 2009;30:1516-24.
29. Lubrano C, Mariani S, Badiali M, et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes (Lond). 2010;34:1404-14.
30. Knopp RH, Gitter H, Truitt T, et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J. 2003;24:729-41.
31. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 1990;323:946-55.
32. Buchwald H, Rudser KD, Williams SE, et al. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias. Ann Surg. 2010;251:1034-40.
33. Pohle-Krauza RJ, McCarroll ML, Pasini DD, et al. Age and gender exert differential effects on blood lipids in patients after LAGB and LRYGB. Surg Obes Relat Dis. 2011;7:170-5.
34. Sarzynski MA, Jacobson P, Rankinen T, et al. Association of GWAS-based candidate genes with HDL-cholesterol levels before and after bariatric surgery in the Swedish Obese Subjects Study. J Clin Endocrinol Metab. 2011;96:953-7.
35. Sarzynski MA, Jacobson P, Rankinen T, et al. Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans. J Clin Endocrinol Metab. 2006;91:4657-63.
36. Martin GR, Loredo JC, Sun G. Lack of association of ghrelin precursor gene variants and percentage body fat or serum lipid profiles. Obesity. 2008;16:908-12.
37. Boes E, Coassin S, Kollerits B, et al. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review. Exp Gerontol. 2009;44:136-60.
38. Cheng KC, Li YX, Asakawa A, et al. The role of ghrelin in energy homeostasis and its potential clinical relevance. Int J Mol Med. 2010;26:771-8.
39. Brolin RE, Bradley LJ, Wilson AC, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4:464-9.